Revista Española de Quimioterapia

Sociedad Española de Quimioterapia

Journal websitePeer review: Other
Evaluation status available after sign-in
Follow this journal
PrintDownload PDF

About the journal

Revista Española de Quimioterapia is an open-access journal published by Sociedad Española de Quimioterapia in Spain, publishing in english and spanish. It is listed in DOAJ and MEDLINE according to the sources read. Declared review time at DOAJ: 8 weeks. Facts are reproduced as recorded at their sources with their capture dates; PublishLens indicators are available after sign-in.

Basic facts

Publisher
Sociedad Española de Quimioterapia
ISSN
0214-3429 · 1988-9518
Country
Spain
Languages
english, spanish
Access
Open access
Articles in DOAJ
0
Declared review time
8 weeks
Declared peer-review model
other
Official website
https://seq.es/revista-de-la-seq-pag/

Index listings

  • DOAJ · 2023-08-04
  • MEDLINE · 1998-01-01
Indexing
DOAJ · MEDLINE
APC
—
Declared review time (DOAJ)
8 weeks — journal-declared only (not measured)
Activity (OpenAlex)
Active — latest works 2026
PublishLens list status
Shown after sign-in
Counts for promotion at your university?
Choose your university and rank below ↓

Methodology signals (dated facts from their sources)

Details of the evaluation under the published methodology are shown to signed-in users (free).

Create a free account to view the evaluation

Journal profile

Descriptive metadata from public sources (DOAJ, OpenAlex, PubMed) as of the capture date shown — contains no assessment or judgment.

Articles in DOAJ

0

Average review time (journal-declared via DOAJ)

8weeks

Works in OpenAlex

724

Last recorded publication year

2026

Reported by OpenAlex in 2 of 3 sources (CC0 flags, not verified indexing)DOAJSciELOOpenAlex Core

h-index

27

i10-index

109

From OpenAlex open data (CC0).

Editorial & policy9
Last DOAJ review date
2023-08-04
Added to DOAJ
2023-08-04
Declared plagiarism screening
Not declared
Other fees beyond APC
No
Editorial board
Official page ↗
Norwegian register (HK-dir)— 2026
Level 1 — approved scholarly channel
Open references deposited at Crossref
0%
ORCID iDs in current deposits
93%
Peer-review policy
View policy
Identity & continuity2
Source type
journal
NLM unique ID (PubMed)
9108821
Classification5

Subjects (DOAJ)

Medicine: Internal medicine: Specialties of internal medicineScience: Microbiology

LCC codes

RRC581-951QR1-502

Subject areas

  • Antibiotic Resistance in Bacteria
  • Antibiotic Resistance in Bacteria
  • Antibiotic Resistance in Bacteria
  • Antibiotic Use and Resistance
  • COVID-19 Clinical Research Studies
  • Bacterial Identification and Susceptibility Testing
  • Bacterial Identification and Susceptibility Testing
  • Bacterial Identification and Susceptibility Testing
Show all subjects (75)
  • SARS-CoV-2 and COVID-19 Research
  • Antibiotic Use and Resistance
  • Antibiotics Pharmacokinetics and Efficacy
  • Antibiotic Use and Resistance
  • Nosocomial Infections in ICU
  • COVID-19 Clinical Research Studies
  • COVID-19 Clinical Research Studies
  • Nosocomial Infections in ICU
  • Pneumonia and Respiratory Infections
  • SARS-CoV-2 and COVID-19 Research
  • SARS-CoV-2 and COVID-19 Research
  • Pneumonia and Respiratory Infections
  • Pneumonia and Respiratory Infections
  • Antibiotics Pharmacokinetics and Efficacy
  • Infections and bacterial resistance
  • Antibiotics Pharmacokinetics and Efficacy
  • Sepsis Diagnosis and Treatment
  • Bacterial Infections and Vaccines
  • Infective Endocarditis Diagnosis and Management
  • Sepsis Diagnosis and Treatment
  • Sepsis Diagnosis and Treatment
  • Infective Endocarditis Diagnosis and Management
  • Infective Endocarditis Diagnosis and Management
  • Streptococcal Infections and Treatments
  • Streptococcal Infections and Treatments
  • Streptococcal Infections and Treatments
  • Antimicrobial Resistance in Staphylococcus
  • Respiratory viral infections research
  • Respiratory viral infections research
  • Antimicrobial Resistance in Staphylococcus
  • Infectious Diseases and Tuberculosis
  • Antimicrobial Resistance in Staphylococcus
  • Antifungal resistance and susceptibility
  • Nosocomial Infections in ICU
  • Urinary Tract Infections Management
  • Fungal Infections and Studies
  • Reproductive tract infections research
  • Antifungal resistance and susceptibility
  • HIV/AIDS Research and Interventions
  • Actinomycetales infections and treatment
  • Urinary Tract Infections Management
  • Urinary Tract Infections Management
  • Antifungal resistance and susceptibility
  • Neonatal and Maternal Infections
  • Respiratory viral infections research
  • Neonatal and Maternal Infections
  • Orthopedic Infections and Treatments
  • Bacterial Infections and Vaccines
  • Bacterial Infections and Vaccines
  • Mycobacterium research and diagnosis
  • Long-Term Effects of COVID-19
  • Long-Term Effects of COVID-19
  • Reproductive tract infections research
  • Infectious Diseases and Tuberculosis
  • Mycobacterium research and diagnosis
  • Infectious Diseases and Tuberculosis
  • Reproductive tract infections research
  • Infection Control in Healthcare
  • HIV/AIDS Research and Interventions
  • HIV/AIDS Research and Interventions
  • Clostridium difficile and Clostridium perfringens research
  • Clostridium difficile and Clostridium perfringens research
  • Neutropenia and Cancer Infections
  • Influenza Virus Research Studies
  • Influenza Virus Research Studies
  • SARS-CoV-2 detection and testing
  • SARS-CoV-2 detection and testing

Keywords (DOAJ)

  • microbiology
  • infectious diseases
  • bacteriology
  • virology
  • mycology
  • parasitology

Community confirmations — what users saw in MJL or Scopus Sources; not platform verification and never part of any score.

Loading community confirmations…
How do we evaluate?Publisher of this journal? Appeal a derived assessment or request a factual correction

The journal's record in other sources:Web of Science MJLDOAJ

Everything shown here is produced automatically from named sources (DOAJ, OpenAlex, Crossref, PubMed, the Norwegian register) as of its capture date, with no human editing. Facts appear as recorded at the source; derived scores (PCI, PTD, PublishLens score) follow a published methodology. Not a judgement on the journal, not an official accreditation, not advice.

Wrong items are corrected automatically by re-reading the source (24 h for daily sources, 7 days for weekly ones) with a dated change log, and each item links to its source record. PublishLens-derived assessments are contested through the appeals mechanism (15 working days). Appeals · Indicator guide

Norwegian register data: Kanalregisteret (HK-dir, Norway) — CC BY 4.0 / NLOD — adapted: level extracted per year · OASPA member list — CC BY

Last automated source read: